Osman B. Zulfikar

Fatih, TR 
Fatih, TR 

Overview

Osman Zulfikar practices practicing medicine in Fatih, Turkey.

His clinical expertise encompasses Blood Clots, Hemophilia A, Hemophilia B, and Hemophilic Arthropathy.

He is actively involved in clinical research, co-authoring 8 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Fatih, Turkey
Other Locations
Istanbul, Turkey

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 3, Prospective, Multicenter, Uncontrolled, Open-Label Clinical Study to Determine the Efficacy, Safety, and Tolerability of rVWF With or Without ADVATE in the Treatment and Control of Bleeding Episodes, the Efficacy and Safety of rVWF in Elective and Emergency Surgeries, and the Pharmacokinetics (PK) of rVWF in Children Diagnosed With Severe Von Willebrand Disease
A Phase 3, Prospective, Multicenter, Uncontrolled, Open-Label Clinical Study to Determine the Efficacy, Safety, and Tolerability of rVWF With or Without ADVATE in the Treatment and Control of Bleeding Episodes, the Efficacy and Safety of rVWF in Elective and Emergency Surgeries, and the Pharmacokinetics (PK) of rVWF in Children Diagnosed With Severe Von Willebrand Disease
Enrollment Status: Completed
Publish Date: May 15, 2026
Intervention Type: Biological
Study Drugs: Von Willebrand Factor, Factor VIII
Study Phase: Phase 3

8 Total Publications

Marstacimab for People with Severe Hemophilia A or Moderate to Severe Hemophilia B Without Inhibitors: A Plain Language Summary of Publication of the BASIS Study.
Marstacimab for People with Severe Hemophilia A or Moderate to Severe Hemophilia B Without Inhibitors: A Plain Language Summary of Publication of the BASIS Study.
Journal: Therapeutic advances in hematology
Published: January 28, 2026

Frequently Asked Questions about Osman B. Zulfikar

Is Osman B. Zulfikar a top-rated expert for Blood Clots?

MediFind is an objective health platform that identifies experts based on real-world data. Osman B. Zulfikar is classified as an Experienced expert for Blood Clots, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Osman B. Zulfikar participate in research or clinical trials?

Yes. Osman B. Zulfikar has published 8 articles and abstracts on conditions like Blood Clots. You can view a list of Osman B. Zulfikar's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Zulfikar's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile